Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Postma

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Journal of Medical Economics|August 3, 2017
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The NetherlandsM S Jacobs, M W J van Leent, R G Tieleman, et al.
International Journal of Clinical Pharmacy|July 27, 2013
The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthmaJ F M van Boven, E G Hiddink, A G G Stuurman-Bieze, et al.
Sexually Transmitted Infections|July 21, 2001
Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimensI G van Valkengoed, M J Postma, S A Morré, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 28, 2002
[Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations]M J Postma, J J Kwik, W J M J Rutten, et al.
Transfusion Medicine (Oxford, England)|June 10, 2005
Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgeryM van Hulst, Y M Bilgin, L M G van de Watering, et al.
The Netherlands Journal of Medicine|December 21, 2018
Trends in direct oral anticoagulant (DOAC) use: health benefits and patient preferenceL A de Jong, M Koops, J J Gout-Zwart, et al.
Plos One|May 19, 2016
Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in VietnamThi-Phuong-Lan Nguyen, E Pamela Wright, Thanh-Trung Nguyen, et al.
Vox Sanguinis|January 25, 2003
Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgeryM J Postma, L M G van de Watering, R de Vries, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugsR M Klok, J R B J Brouwers, P B Van den Berg, et al.
International Journal of STD & AIDS|October 1, 2008
Cost-effectiveness estimates for antenatal HIV testing in the NetherlandsM H Rozenbaum, G Verweel, D K F Folkerts, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Journal of Medical Economics|August 3, 2017
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The NetherlandsM S Jacobs, M W J van Leent, R G Tieleman, et al.
International Journal of Clinical Pharmacy|July 27, 2013
The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthmaJ F M van Boven, E G Hiddink, A G G Stuurman-Bieze, et al.
Sexually Transmitted Infections|July 21, 2001
Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimensI G van Valkengoed, M J Postma, S A Morré, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 28, 2002
[Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations]M J Postma, J J Kwik, W J M J Rutten, et al.
Transfusion Medicine (Oxford, England)|June 10, 2005
Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgeryM van Hulst, Y M Bilgin, L M G van de Watering, et al.
The Netherlands Journal of Medicine|December 21, 2018
Trends in direct oral anticoagulant (DOAC) use: health benefits and patient preferenceL A de Jong, M Koops, J J Gout-Zwart, et al.
Plos One|May 19, 2016
Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in VietnamThi-Phuong-Lan Nguyen, E Pamela Wright, Thanh-Trung Nguyen, et al.
Vox Sanguinis|January 25, 2003
Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgeryM J Postma, L M G van de Watering, R de Vries, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugsR M Klok, J R B J Brouwers, P B Van den Berg, et al.
International Journal of STD & AIDS|October 1, 2008
Cost-effectiveness estimates for antenatal HIV testing in the NetherlandsM H Rozenbaum, G Verweel, D K F Folkerts, et al.
Pageof 14